Parexel International ($PRXL) raked in a $17.8 million net profit in its fiscal fourth quarter, which ended June 30, a big turnaround from the $1.6 million loss the company took in the period last year. Parexel credits a 26.4% spike in revenue, bringing in $392.6 million for the quarter, due in part to the company's decrease in year-to-year restructuring charges. The company saw its largest revenue growth in clinical research, which pulled in $292 million in the quarter. Release